Carcinoma hepatocelular en hígado no cirrótico: características clínicas y resultados en Veracruz, México

Wallace, 2015, The evolving epidemiology of hepatocellular carcinoma: A global perspective, Expert Rev Gastroenterol Hepatol, 9, 765, 10.1586/17474124.2015.1028363 Forner, 2009, Diagnóstico y tratamiento del carcinoma hepatocelular, Med Clin (Barc), 132, 272, 10.1016/j.medcli.2008.11.024 Armstrong, 2006, The prevalence of hepatitis C virus infection in the United States, 1999 through 2002, Ann Intern Med, 144, 705, 10.7326/0003-4819-144-10-200605160-00004 Alkofer, 2011, Hepatocellular cancer in the non-cirrhotic liver, J Visc Surg, 148, 3, 10.1016/j.jviscsurg.2010.12.012 Trevisani, 2010, Hepatocellular carcinoma in non-cirrhotic liver: A reappraisal, Dig Liver Dis, 42, 341, 10.1016/j.dld.2009.09.002 Bernal-Reyes, 2019, Consenso mexicano de la enfermedad por hígado graso no alcohólico, Rev Gastroenterol Mex, 84, 69 Kawada, 2009, Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis, J Gastroenterol, 44, 1190, 10.1007/s00535-009-0112-0 Faber, 2013, Long-term results of liver resection for hepatocellular carcinoma in noncirrhotic liver, Surgery, 153, 510, 10.1016/j.surg.2012.09.015 Xu, 2008, Clinicopathologic features and long-term outcomes of Chinese patients with hepatocellular carcinoma in non-cirrhotic liver, Dig Surg, 25, 376, 10.1159/000170881 Giannini, 2013, Hepatocellular carcinoma in patients without cirrhosis in Italy, Dig Liver Dis, 45, 164, 10.1016/j.dld.2012.08.018 Trevisani, 1995, Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients, Cancer, 75, 2220, 10.1002/1097-0142(19950501)75:9<2220::AID-CNCR2820750906>3.0.CO;2-4 Núñez Martínez, 2011, Estudio descriptivo de la experiencia sobre carcinoma hepatocelular en hígado no cirrótico, Gastroenterol Hepatol, 34, 322, 10.1016/j.gastrohep.2011.02.002 Chang, 2004, Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver, Arch Surg, 139, 320, 10.1001/archsurg.139.3.320 Ho, 2018, Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection, Sci Rep, 8, 1 Johnson, 2015, Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach—The ALBI grade, J Clin Oncol, 33, 550, 10.1200/JCO.2014.57.9151 Vallet-Pichard, 2007, FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest, Hepatology, 46, 32, 10.1002/hep.21669 Wai, 2003, A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C, Hepatology, 38, 518, 10.1053/jhep.2003.50346 Westin, 2008, A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection, Scand J Gastroenterol, 43, 73, 10.1080/00365520701514461 Hackl, 2016, Liver surgery in cirrhosis and portal hypertension, World J Gastroenterol, 22, 2725, 10.3748/wjg.v22.i9.2725 Shukla, 2013, Binge ethanol and liver: New molecular developments, Alcohol Clin Exp Res, 37, 550, 10.1111/acer.12011 Grundy, 2004, Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition, Circulation., 109, 433, 10.1161/01.CIR.0000111245.75752.C6 Standish, 2006, An appraisal of the histopathological assessment of liver fibrosis, Gut, 55, 569, 10.1136/gut.2005.084475 Song, 2012, Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period, Clin Mol Hepatol, 18, 258, 10.3350/cmh.2012.18.3.258 Levy, 2002, Staging of hepatocellular carcinoma: Assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto, Gut, 50, 881, 10.1136/gut.50.6.881 Elshamy, 2016, Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria, World J Hepatol, 8, 874, 10.4254/wjh.v8.i21.874 Wong, 2014, Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the US, Hepatology, 59, 2188, 10.1002/hep.26986 Meza-Junco, 2004, Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico, Gastroenterol Hepatol, 27, 11, 10.1016/S0210-5705(03)70438-5 Ladrón de Guevara, 2009, Hepatocellular carcinoma: Epidemiological profile from a cohort of federal employees in Mexico, Ann Hepatol, 8, 212, 10.1016/S1665-2681(19)31768-5 Cisneros-Garza, 2018, Characterization of hepatocellular carcinoma in Mexico, Rev Gastroenterol Mex, 83, 223 Moreno-Luna, 2005, Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma, BMC Cancer., 5, 142, 10.1186/1471-2407-5-142